According to our latest research, the global Mitomycin C market size reached USD 178.4 million in 2024, reflecting steady growth driven by rising cancer incidences and expanding therapeutic applications. The market is expected to register a robust CAGR of 7.1% during the forecast period, with the Mitomycin C market size projected to reach USD 328.7 million by 2033. The primary growth factor remains the increasing utilization of Mitomycin C in oncology, especially for bladder and gastrointestinal cancers, coupled with its expanding role in ophthalmic procedures and ongoing research activities. https://growthmarketreports.com/report/mitomycin-c-market-global-industry-analysis